Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect
For patients with poor baseline nutritional status or sarcopenia, it is necessary to ensure adequate energy and high-quality protein intake
On the cardiovascular side, the SUSTAIN-6 trial in 2016 was one of the first to report a significant reduction in major adverse cardiovascular events with semaglutide in adults with type 2 diabetes and high cardiovascular risk (Marso et al., NEJM, 2016)
These covariates included patient characteristics as well as tumor characteristics known to have associations with BMI, including stage at diagnosis, histology, and breast cancer subtype
Anju Methil is the most preferred choice for your glutathione injection in Mumbai: Expertise As one of the leading dermatologist in Andheri, Mumbai, Dr
Each vial contains 10 mL of compounded glutathione at 200 mg/mL